Sanara MedTech Inc. (SMTI) Profit Margins
Over the twelve months to 2026-06-30, Sanara MedTech Inc. (SMTI) had gross margin 93.0%, operating margin 7.7%, net margin -29.2%, free cash flow margin 4.1%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SMTISanara MedTech Inc.Follow SMTI — free
—
Price chart with a free account
- Market cap
- 301.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 63.8% | 32.0% | 54.1% | 69.5% | 73.5% | 82.9% | 87.2% | 91.3% | 89.7% | 89.6% | 90.4% | 86.1% | 87.9% | 90.6% | 92.7% | 93.0% | |
| Operating margin | -226.9% | — | — | — | -28.6% | -4.9% | 1.9% | -8.6% | -23.3% | -32.3% | -30.6% | -27.3% | -6.5% | 1.5% | 7.1% | 7.7% | |
| Net margin | -576.6% | -157.2% | -240.3% | -86.5% | -39.8% | -7.5% | 5.3% | -10.3% | -23.9% | -28.5% | -32.8% | -17.3% | -6.6% | -11.2% | -36.4% | -29.2% | |
| FCF margin | — | — | -107.3% | -64.4% | -35.8% | 7.4% | -2.9% | 4.6% | -20.0% | -29.4% | -20.7% | -12.4% | -5.4% | -0.3% | 2.1% | 4.1% |
USD millions · SEC XBRL
Sanara MedTech Inc. — questions
- What is Sanara MedTech Inc.'s gross margin?
- 93.0% over the twelve months to 2026-06-30.
- What is Sanara MedTech Inc.'s operating margin?
- 7.7% over the twelve months to 2026-06-30.
- What is Sanara MedTech Inc.'s net profit margin?
- -29.2% over the twelve months to 2026-06-30.
Every figure on this page comes from Sanara MedTech Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.